Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
Treatment Satisfaction In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With Pact-Q2 At Baseline And 12-Month Follow-Up: Prefer In Af Registry.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Brüggenjürgen B, Schliephacke T, Darius H, De CR, Le HJ, Reimitz PE, Schilling RJ, Schwertfeger M, Zamorano JL, Kirchhof P.
PMID: 27201497
Value Health. 2014 Nov;17(7):A497. doi: 10.1016/j.jval.2014.08.1484. Epub 2014 Oct 26.

No abstract available.

Cite
Brüggenjürgen B, Schliephacke T, Darius H, et al. Treatment Satisfaction In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With Pact-Q2 At Baseline And 12-Month Follow-Up: Prefer In Af Registry. Value Health. 2014;17(7):A497doi: 10.1016/j.jval.2014.08.1484.
Brüggenjürgen, B., Schliephacke, T., Darius, H., De, C. R., Le, H. J., Reimitz, P. E., Schilling, R. J., Schwertfeger, M., Zamorano, J. L., & Kirchhof, P. (2014). Treatment Satisfaction In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With Pact-Q2 At Baseline And 12-Month Follow-Up: Prefer In Af Registry. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A497. https://doi.org/10.1016/j.jval.2014.08.1484
Brüggenjürgen, B, et al. "Treatment Satisfaction In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With Pact-Q2 At Baseline And 12-Month Follow-Up: Prefer In Af Registry." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A497. doi: https://doi.org/10.1016/j.jval.2014.08.1484
Brüggenjürgen B, Schliephacke T, Darius H, De CR, Le HJ, Reimitz PE, Schilling RJ, Schwertfeger M, Zamorano JL, Kirchhof P. Treatment Satisfaction In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With Pact-Q2 At Baseline And 12-Month Follow-Up: Prefer In Af Registry. Value Health. 2014 Nov;17(7):A497. doi: 10.1016/j.jval.2014.08.1484. Epub 2014 Oct 26. PMID: 27201497.
Copy Download .nbib Format: NLM
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER).

Thrombosis journal

Beyer-Westendorf J, Camm AJ, Fox KAA, Le Heuzey JY, Haas S, Turpie AGG, Virdone S, Kakkar AK.
PMID: 31169831
Thromb J. 2019 Apr 25;17:7. doi: 10.1186/s12959-019-0195-7. eCollection 2019.

BACKGROUND: Real-world data on non-vitamin K oral anticoagulants (NOACs) are essential in determining whether evidence from randomised controlled clinical trials translate into meaningful clinical benefits for patients in everyday practice. RIVER (RIVaroxaban Evaluation in Real life setting) is an...

Cite
Beyer-Westendorf J, Camm AJ, Fox KAA, et al. International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER). Thromb J. 2019;17:7doi: 10.1186/s12959-019-0195-7.
Beyer-Westendorf, J., Camm, A. J., Fox, K. A. A., Le Heuzey, J. Y., Haas, S., Turpie, A. G. G., Virdone, S., Kakkar, A. K. (2019). International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER). Thrombosis journal, 177. https://doi.org/10.1186/s12959-019-0195-7
Beyer-Westendorf, Jan, et al. "International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)." Thrombosis journal vol. 17 (2019): 7. doi: https://doi.org/10.1186/s12959-019-0195-7
Beyer-Westendorf J, Camm AJ, Fox KAA, Le Heuzey JY, Haas S, Turpie AGG, Virdone S, Kakkar AK. International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER). Thromb J. 2019 Apr 25;17:7. doi: 10.1186/s12959-019-0195-7. eCollection 2019. PMID: 31169831; PMCID: PMC6482585.
Copy Download .nbib Format: NLM
[Guidelines for cardiac pacing and cardiac resynchronization therapy].

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology

Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, Gasparini M, Linde C, Morgado FB, Oto A, Sutton R, Trusz-Gluza M, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Priori SG, Blomström-Lundqvist C, Brignole M, Terradellas JB, Camm J, Castellano P, Cleland J, Farre J, Fromer M, Le Heuzey JY, Lip GY, Merino JL, Montenero AS, Ritter P, Schalij MJ, Stellbrink C.
PMID: 18717216
Rev Port Cardiol. 2008 May;27(5):639-87.

No abstract available.

Cite
Vardas PE, Auricchio A, Blanc JJ, et al. Orientações para pacing cardíaco e terapia de ressincronização cardíaca. [Guidelines for cardiac pacing and cardiac resynchronization therapy]. Rev Port Cardiol. 2008;27(5):639-87
Vardas, P. E., Auricchio, A., Blanc, J. J., Daubert, J. C., Drexler, H., Ector, H., Gasparini, M., Linde, C., Morgado, F. B., Oto, A., Sutton, R., Trusz-Gluza, M., Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Funck-Brentano, C., Filippatos, G., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Priori, S. G., Blomström-Lundqvist, C., Brignole, M., Terradellas, J. B., Camm, J., Castellano, P., Cleland, J., Farre, J., Fromer, M., Le Heuzey, J. Y., Lip, G. Y., Merino, J. L., Montenero, A. S., Ritter, P., Schalij, M. J., & Stellbrink, C. (2008). Orientações para pacing cardíaco e terapia de ressincronização cardíaca. [Guidelines for cardiac pacing and cardiac resynchronization therapy]. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 27(5), 639-87.
Vardas, Panos E, et al. "Orientações para pacing cardíaco e terapia de ressincronização cardíaca." [Guidelines for cardiac pacing and cardiac resynchronization therapy]. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology vol. 27,5 (2008): 639-87.
Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, Gasparini M, Linde C, Morgado FB, Oto A, Sutton R, Trusz-Gluza M, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Priori SG, Blomström-Lundqvist C, Brignole M, Terradellas JB, Camm J, Castellano P, Cleland J, Farre J, Fromer M, Le Heuzey JY, Lip GY, Merino JL, Montenero AS, Ritter P, Schalij MJ, Stellbrink C. Orientações para pacing cardíaco e terapia de ressincronização cardíaca. [Guidelines for cardiac pacing and cardiac resynchronization therapy]. Rev Port Cardiol. 2008 May;27(5):639-87. Portuguese. PMID: 18717216.
Copy Download .nbib Format: NLM
Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors.

Stroke

Grimaldi-Bensouda L, Le Heuzey JY, Ferrières J, Leys D, Davy JM, Martinez M, Dialla O, Smadja D, Nighoghossian N, Benichou J, Nordon C, Touzé E, Abenhaim L.
PMID: 34253047
Stroke. 2021 Oct;52(10):3121-3131. doi: 10.1161/STROKEAHA.120.032704. Epub 2021 Jul 13.

[Figure: see text].

Cite
Grimaldi-Bensouda L, Le Heuzey JY, Ferrières J, et al. Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors. Stroke. 2021;52(10):3121-3131doi: 10.1161/STROKEAHA.120.032704.
Grimaldi-Bensouda, L., Le Heuzey, J. Y., Ferrières, J., Leys, D., Davy, J. M., Martinez, M., Dialla, O., Smadja, D., Nighoghossian, N., Benichou, J., Nordon, C., Touzé, E., & Abenhaim, L. (2021). Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors. Stroke, 52(10), 3121-3131. https://doi.org/10.1161/STROKEAHA.120.032704
Grimaldi-Bensouda, Lamiae, et al. "Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors." Stroke vol. 52,10 (2021): 3121-3131. doi: https://doi.org/10.1161/STROKEAHA.120.032704
Grimaldi-Bensouda L, Le Heuzey JY, Ferrières J, Leys D, Davy JM, Martinez M, Dialla O, Smadja D, Nighoghossian N, Benichou J, Nordon C, Touzé E, Abenhaim L. Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors. Stroke. 2021 Oct;52(10):3121-3131. doi: 10.1161/STROKEAHA.120.032704. Epub 2021 Jul 13. PMID: 34253047.
Copy Download .nbib Format: NLM
Stroke Prevention in Atrial Fibrillation - Outcomes and Future Directions.

Arrhythmia & electrophysiology review

Mountfort K, Camm J, Lip G, Goette A, Le Heuzey JY.
PMID: 26835091
Arrhythm Electrophysiol Rev. 2014 Nov;3(3):194-200. doi: 10.15420/aer.2014.3.3.194. Epub 2014 Nov 29.

Stroke prevention is central to the management of patients with atrial fibrillation (AF). Vitamin K antagonists (VKAs) are the established and long-standing option for stroke prevention therapy in patients with AF. However, non-VKA oral anticoagulants (NOACs) have recently been...

Cite
Mountfort K, Camm J, et al. Stroke Prevention in Atrial Fibrillation - Outcomes and Future Directions. Arrhythm Electrophysiol Rev. 2014;3(3):194-200doi: 10.15420/aer.2014.3.3.194.
Mountfort, K., Camm, J., Lip, G., Goette, A., & Le Heuzey, J. Y. (2014). Stroke Prevention in Atrial Fibrillation - Outcomes and Future Directions. Arrhythmia & electrophysiology review, 3(3), 194-200. https://doi.org/10.15420/aer.2014.3.3.194
Mountfort, Katrina. "Stroke Prevention in Atrial Fibrillation - Outcomes and Future Directions." Arrhythmia & electrophysiology review vol. 3,3 (2014): 194-200. doi: https://doi.org/10.15420/aer.2014.3.3.194
Mountfort K, Camm J, Lip G, Goette A, Le Heuzey JY. Stroke Prevention in Atrial Fibrillation - Outcomes and Future Directions. Arrhythm Electrophysiol Rev. 2014 Nov;3(3):194-200. doi: 10.15420/aer.2014.3.3.194. Epub 2014 Nov 29. PMID: 26835091; PMCID: PMC4711502.
Copy Download .nbib Format: NLM
Health State In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With The New Eq-5d-5l Questionnaire At Baseline And 12-Month Follow-Up: Prefer In Af Registry.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Brüggenjürgen B, Schliephacke T, Darius H, De CR, Le HJ, Reimitz PE, Schilling RJ, Schwertfeger M, Zamorano JL, Kirchhof P.
PMID: 27201472
Value Health. 2014 Nov;17(7):A493. doi: 10.1016/j.jval.2014.08.1464. Epub 2014 Oct 26.

No abstract available.

Cite
Brüggenjürgen B, Schliephacke T, Darius H, et al. Health State In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With The New Eq-5d-5l Questionnaire At Baseline And 12-Month Follow-Up: Prefer In Af Registry. Value Health. 2014;17(7):A493doi: 10.1016/j.jval.2014.08.1464.
Brüggenjürgen, B., Schliephacke, T., Darius, H., De, C. R., Le, H. J., Reimitz, P. E., Schilling, R. J., Schwertfeger, M., Zamorano, J. L., & Kirchhof, P. (2014). Health State In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With The New Eq-5d-5l Questionnaire At Baseline And 12-Month Follow-Up: Prefer In Af Registry. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A493. https://doi.org/10.1016/j.jval.2014.08.1464
Brüggenjürgen, B, et al. "Health State In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With The New Eq-5d-5l Questionnaire At Baseline And 12-Month Follow-Up: Prefer In Af Registry." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A493. doi: https://doi.org/10.1016/j.jval.2014.08.1464
Brüggenjürgen B, Schliephacke T, Darius H, De CR, Le HJ, Reimitz PE, Schilling RJ, Schwertfeger M, Zamorano JL, Kirchhof P. Health State In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With The New Eq-5d-5l Questionnaire At Baseline And 12-Month Follow-Up: Prefer In Af Registry. Value Health. 2014 Nov;17(7):A493. doi: 10.1016/j.jval.2014.08.1464. Epub 2014 Oct 26. PMID: 27201472.
Copy Download .nbib Format: NLM
Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors.

Stroke

Grimaldi-Bensouda L, Le Heuzey JY, Ferrières J, Leys D, Davy JM, Martinez M, Dialla O, Smadja D, Nighoghossian N, Benichou J, Nordon C, Touzé E, Abenhaim L.
PMID: 34253047
Stroke. 2021 Oct;52(10):3121-3131. doi: 10.1161/STROKEAHA.120.032704. Epub 2021 Jul 13.

BACKGROUND AND PURPOSE: The objective of the study was to assess the effectiveness of individual direct oral anticoagulants versus vitamin K antagonists for primary prevention of stroke (ischemic and hemorrhagic) in routine clinical practice in patients with various clinical...

Cite
Grimaldi-Bensouda L, Le Heuzey JY, Ferrières J, et al. Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors. Stroke. 2021;52(10):3121-3131doi: 10.1161/STROKEAHA.120.032704.
Grimaldi-Bensouda, L., Le Heuzey, J. Y., Ferrières, J., Leys, D., Davy, J. M., Martinez, M., Dialla, O., Smadja, D., Nighoghossian, N., Benichou, J., Nordon, C., Touzé, E., & Abenhaim, L. (2021). Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors. Stroke, 52(10), 3121-3131. https://doi.org/10.1161/STROKEAHA.120.032704
Grimaldi-Bensouda, Lamiae, et al. "Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors." Stroke vol. 52,10 (2021): 3121-3131. doi: https://doi.org/10.1161/STROKEAHA.120.032704
Grimaldi-Bensouda L, Le Heuzey JY, Ferrières J, Leys D, Davy JM, Martinez M, Dialla O, Smadja D, Nighoghossian N, Benichou J, Nordon C, Touzé E, Abenhaim L. Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors. Stroke. 2021 Oct;52(10):3121-3131. doi: 10.1161/STROKEAHA.120.032704. Epub 2021 Jul 13. PMID: 34253047.
Copy Download .nbib Format: NLM
Discontinuation And Hospitalisation Rates In Patients With Atrial Fibrillation: Follow-Up Results Of The Prefer In Af Registry.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Brüggenjürgen B, Schliephacke T, Darius H, De Caterina R, Le Heuzey JY, Pittrow D, Reimitz PE, Schilling RJ, Zamorano JL, Kirchhof P.
PMID: 27201363
Value Health. 2014 Nov;17(7):A473. doi: 10.1016/j.jval.2014.08.1346. Epub 2014 Oct 26.

No abstract available.

Cite
Brüggenjürgen B, Schliephacke T, Darius H, et al. Discontinuation And Hospitalisation Rates In Patients With Atrial Fibrillation: Follow-Up Results Of The Prefer In Af Registry. Value Health. 2014;17(7):A473doi: 10.1016/j.jval.2014.08.1346.
Brüggenjürgen, B., Schliephacke, T., Darius, H., De Caterina, R., Le Heuzey, J. Y., Pittrow, D., Reimitz, P. E., Schilling, R. J., Zamorano, J. L., & Kirchhof, P. (2014). Discontinuation And Hospitalisation Rates In Patients With Atrial Fibrillation: Follow-Up Results Of The Prefer In Af Registry. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A473. https://doi.org/10.1016/j.jval.2014.08.1346
Brüggenjürgen, B, et al. "Discontinuation And Hospitalisation Rates In Patients With Atrial Fibrillation: Follow-Up Results Of The Prefer In Af Registry." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A473. doi: https://doi.org/10.1016/j.jval.2014.08.1346
Brüggenjürgen B, Schliephacke T, Darius H, De Caterina R, Le Heuzey JY, Pittrow D, Reimitz PE, Schilling RJ, Zamorano JL, Kirchhof P. Discontinuation And Hospitalisation Rates In Patients With Atrial Fibrillation: Follow-Up Results Of The Prefer In Af Registry. Value Health. 2014 Nov;17(7):A473. doi: 10.1016/j.jval.2014.08.1346. Epub 2014 Oct 26. PMID: 27201363.
Copy Download .nbib Format: NLM
Showing 1 to 8 of 8 entries